Skip to main content

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    The Nike Mag Shoe, Complete with "Adaptive Fit," to be Released in Partnership with The Michael J. Fox Foundation in Effort to Speed a Cure for Parkinson's

    New York and Beaverton, Oregon, Oct. 4, 2016 -- Almost 30 years ago, Nike inspired a future vision of footwear -- an individually responsive shoe that senses the wearer and adapts on its own. The…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Selected as Finalist in Competition to Raise Awareness of Clinical Trial Participation

    The Michael J. Fox Foundation for Parkinson's Research (MJFF) is one of 14 finalists selected to attend the "Inspiring Hope" Ideathon, an initiative to raise awareness of clinical trial participation…
    Learn more

  • Default content image

    Parkinson's Research Leaders Outline Roadmap to Personalized Medicine

    NEW YORK -- In an editorial recently published in Personalized Medicine, authors from The Michael J. Fox Foundation for Parkinson's Research and J. William Langston, MD, chief scientific officer and…
    Learn more

  • Default content image

    Michael J. Fox Foundation Vice President of Medical Communications Joins Alliance for Patient Access Meeting

    NEW YORK, NY -- Today, Rachel Dolhun, MD, vice president of medical communications at MJFF, will join a coalition of physicians for the inaugural meeting of the Physicians Neurodegenerative Disease…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Expands Fox Trial Finder to Accelerate Research in Atypical Parkinsonism

    Atypical parkinsonisms, rare conditions that affect a significant number of individuals, are often misdiagnosed as Parkinson's Expansion of Fox Trial Finder aims to increase engagement in atypical…
    Learn more

  • Default content image

    Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson's Trust Collaborate to Assess the Clinical Use and Development of Nilotinib in Parkinson's Disease

    Investigators will focus on safety for long-term use in non-cancer patients Partners aim to design and co-fund a multi-site trial to begin in 2017; trial endpoints would include precise biological…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Announces $2M Prize for First PET Tracer to Visualize Key Parkinson's Protein in Living Brain

    Tracer to visualize alpha-synuclein protein would aid in Parkinson's diagnosis, progression tracking and testing of novel therapies MJFF will award a $2 million alpha-synuclein imaging prize to the…
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.